Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLICOR: Lidocaine in colorectal cancer surgery
NCT05250791Unknown
- Sponsor
- Imperial College London
- Start
- Feb 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in colorectal cancer (CRC) comparing Lidocaine with Placebo (2 arms). Primary endpoints: Feasibility of recruitment, Trial retention and 5 more. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05250791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05250791.